Concepedia

Mark J.A. Schoonderwoerd

MJ

13

Publications

1K

Citations

12

H-Index

2017

Active since

Affiliations

Leiden University Medical Center(Current)

Leiden University

Mark J.A. Schoonderwoerd is an author at Leiden University Medical Center specializing in cancer research, tumor microenvironment, and medicine.

Top concepts

Publications per year

2017–2022

13

Publications

13

Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy

Marieke F. Fransen, Mark J.A. Schoonderwoerd, Philipp Knopf et al. · JCI Insight · 2018 · 370 citations · Full text

, , +14

Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis

Madelon Paauwe, Mark J.A. Schoonderwoerd, Roxan F.C.P. Helderman et al. · Clinical Cancer Research · 2018 · 180 citations · Full text

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

Jan Willem Kleinovink, Koen A. Marijt, Mark J.A. Schoonderwoerd et al. · OncoImmunology · 2017 · 135 citations · Full text

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

Sumit Kumar, Mark J.A. Schoonderwoerd, Jessie S. Kroonen et al. · Gut · 2022 · 120 citations · Full text

Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy

Mark J.A. Schoonderwoerd, Maaike F.M. Koops, Ricardo A. Angela et al. · Clinical Cancer Research · 2020 · 47 citations · Full text

Rows per page

1–5 of 13